Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
Status:
Recruiting
Trial end date:
2020-05-20
Target enrollment:
Participant gender:
Summary
In our center up to 25% of the hospitalized patients with COVID-19 progress and need an
intensive care unit. It is urgent to find measures that can avoid this progression to severe
stages of the disease. We hypothesize that the use of anti-inflammatory drugs used at the
time they start hyperinflammation episodes could improve symptoms and prognosis of patients
and prevent their progression sufficiently to avoid their need for be admitted to an
Intensive Care Unit.